From Yahoo Finance: 2025-04-23 17:48:00

Verona Pharma plc (NASDAQ: VRNA) is among the best multibagger stocks to buy according to billionaires. The stock has seen a 282.12% gain in the past year, with 42 hedge fund holders and 10 billionaire holders. It specializes in developing therapies for chronic respiratory diseases, with its leading product candidate, ensifentrine, showing promising results.

The recent US trade tariffs have caused significant volatility in the equity markets, with the S&P 500 dropping 6% in one day. This has led to caution among investors, resulting in the largest two-day loss in history for the world’s wealthiest individuals, totaling $536 billion in losses. Prominent figures like Bill Gross have warned of continued market turmoil.

Despite the market turbulence, opportunities are arising as stock valuations have decreased. Billionaires are taking advantage of the dip in prices, following Warren Buffett’s advice to be greedy when others are fearful. The recent pullbacks have brought stock valuations back to historical norms, providing potential value investment opportunities.

Verona Pharma plc (NASDAQ: VRNA) is a biopharmaceutical company that develops innovative therapies for chronic respiratory diseases like COPD. With a 282% gain over the past year, the stock has attracted attention. Following the FDA approval of its flagship drug Ohtuvayre for COPD treatment, sales are projected to exceed $1 billion by 2029.

Verona Pharma plc (NASDAQ: VRNA) has partnered with Nuance Pharma for the launch of Ohtuvayre in Macau, expanding its revenue base. The company is also focusing on strengthening its pipeline with phase 2 clinical trials for glycopyrrolate. While VRNA ranks 4th on the list of best multibagger stocks, AI stocks are seen as holding greater promise for higher returns in a shorter timeframe.



Read more at Yahoo Finance: Among the Best Multibagger Stocks to Buy According to Billionaires